Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Jensen, Helle ^a   Folkersen, Lasse ^b   Skov, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD161 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; GRANULYSIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; KLRD1 PROTEIN, HUMAN; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ANTIGEN PRESENTING CELL; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; PHENOTYPE; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; FEMALE; GENE SILENCING; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PHYSIOLOGY;

HUMAN HERPESVIRUS 5;

CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SIGNAL TRANSDUCTION;

EID: 84864741235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041577     Document Type: Article

References (54)

1. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
2. Das H, Groh V, Kuijl C, Sugita M, Morita CT, et al. (2001) MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15: 83-93.
3. Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, et al. (2007) CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132: 2346-2358.
4. Capraru D, Muller A, Csernok E, Gross WL, Holl-Ulrich K, et al. (2008) Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol 127: 144-150.
5. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T, (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100: 9452-9457.
6. Yang D, Wang H, Ni B, He Y, Li J, et al. (2009) Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus. Mol Immunol 46: 1432-1442.
7. Saez-Borderias A, Guma M, Angulo A, Bellosillo B, Pende D, et al. (2006) Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 36: 3198-3206.
8. Reddehase MJ, (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2: 831-844.
9. Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J, (2009) ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 39: 3207-3216.
10. Spies T, (2008) Regulation of NKG2D ligands: a purposeful but delicate affair. Nat Immunol 9: 1013-1015.
11. Cerwenka A, Lanier LL, (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1: 41-49.
12. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, et al. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377.
13. Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, et al. (2006) TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 129: 2416-2425.
14. Vetter CS, Lieb W, Brocker EB, Becker JC, (2004) Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma. Br J Cancer 91: 1495-1499.
15. Ashiru O, Bennett NJ, Boyle LH, Thomas M, Trowsdale J, et al. (2009) NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol 83: 12345-12354.
16. Bennett NJ, Ashiru O, Morgan FJ, Pang Y, Okecha G, et al. (2010) Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J Immunol 185: 1093-1102.
17. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
18. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, et al. (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197: 1427-1439.
19. Nachmani D, Lankry D, Wolf DG, Mandelboim O, (2010) The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 11: 806-813.
20. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
21. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, et al. (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25: 2433-2437.
22. Houchins JP, Yabe T, McSherry C, Bach FH, (1991) DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173: 1017-1020.
23. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
24. Meyers JH, Ryu A, Monney L, Nguyen K, Greenfield EA, et al. (2002) Cutting edge: CD94/NKG2 is expressed on Th1 but not Th2 cells and costimulates Th1 effector functions. J Immunol 169: 5382-5386.
25. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, et al. (2012) Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484: 514-518.
26. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
27. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM, (1997) Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 158: 2680-2688.
28. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM, (1998) Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 41: 2108-2116.
29. Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, et al. (2001) A novel serum protein that is selectively produced by cytotoxic lymphocytes. J Immunol 166: 6404-6412.
30. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM, (2007) Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 319: 41-52.
31. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
32. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
33. Groh V, Smythe K, Dai Z, Spies T, (2006) Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol 7: 755-762.
34. Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, et al. (2007) Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis 13: 837-846.
35. Pingiotti E, Cipriani P, Marrelli A, Liakouli V, Fratini S, et al. (2007) Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage. Ann N Y Acad Sci 1107: 32-41.
36. Sallusto F, Langenkamp A, Geginat J, Lanzavecchia A, (2000) Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol 251: 167-171.
37. Appay V, van Lier RA, Sallusto F, Roederer M, (2008) Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
38. Lippincott-Schwartz J, Glickman J, Donaldson JG, Robbins J, Kreis TE, et al. (1991) Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism. J Cell Biol 112: 567-577.
39. Roda-Navarro P, Reyburn HT, (2009) The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation. J Biol Chem 284: 16463-16472.
40. Chen HW, Liao CH, Ying C, Chang CJ, Lin CM, (2006) Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Clin Immunol 119: 21-31.
41. Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, et al. (2009) Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J Exp Med 206: 793-805.
42. Aliahmad P, Kaye J, (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205: 245-256.
43. Aliahmad P, de la Torre B, Kaye J, (2010) Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol 11: 945-952.
44. Lieto LD, Borrego F, You CH, Coligan JE, (2003) Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15. J Immunol 171: 5277-5286.
45. Bangs SC, Baban D, Cattan HJ, Li CK, McMichael AJ, et al. (2009) Human CD4+ memory T cells are preferential targets for bystander activation and apoptosis. J Immunol 182: 1962-1971.
46. Kaneko K, Miyabe Y, Takayasu A, Fukuda S, Miyabe C, et al. (2011) Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Ther 13: R158.
47. Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, et al. (2002) Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum 46: 2878-2883.
48. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109: 3625-3632.
49. Andresen L, Jensen H, Pedersen MT, Hansen KA, Skov S, (2007) Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J Immunol 179: 8235-8242.
50. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
51. Aramburu J, Balboa MA, Izquierdo M, Lopez-Botet M, (1991) A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 147: 714-721.
52. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ, (2009) GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10: 161.
53. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
54. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.